Verastem (VSTM) Accumulated Expenses: 2018-2024

Historic Accumulated Expenses for Verastem (VSTM) over the last 6 years, with Dec 2024 value amounting to $26.0 million.

  • Verastem's Accumulated Expenses rose 101.87% to $44.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.7 million, marking a year-over-year increase of 101.87%. This contributed to the annual value of $26.0 million for FY2024, which is N/A change from last year.
  • Per Verastem's latest filing, its Accumulated Expenses stood at $26.0 million for FY2024, which was up 73.21% from $15.0 million recorded in FY2022.
  • In the past 5 years, Verastem's Accumulated Expenses registered a high of $26.0 million during FY2024, and its lowest value of $14.7 million during FY2020.
  • Moreover, its 2-year median value for Accumulated Expenses was $20.5 million (2022), whereas its average is $20.5 million.
  • Per our database at Business Quant, Verastem's Accumulated Expenses declined by 24.30% in 2020 and then climbed by 6.56% in 2021.
  • Yearly analysis of 4 years shows Verastem's Accumulated Expenses stood at $14.7 million in 2020, then rose by 6.56% to $15.6 million in 2021, then decreased by 4.08% to $15.0 million in 2022, then reached $26.0 million in 2024.